Stern R S, Parrish J A, Fitzpatrick T B, Bleich H L
J Invest Dermatol. 1985 Feb;84(2):135-8. doi: 10.1111/1523-1747.ep12275374.
To determine the extent of clinical actinic damage that occurred in association with exposure to oral methoxsalen photochemotherapy (PUVA), dermatologists at 16 university centers assessed the wrinkling, telangiectasia, and altered skin markings on the buttocks and the dorsa of the hands among 1380 patients treated with PUVA. These changes are similar to those seen in skin that is chronically exposed to sunlight. After more than 5 years of prospective study, patients with psoriasis exposed to PUVA showed a significant dose-dependent increase in the prevalence of clinical actinic degeneration of the skin of the buttocks (p less than .05, F-test). The prevalence of moderate or severe change among those patients exposed to high doses of PUVA (more than 160 treatments) was low (11%). The degree of increased clinical actinic degeneration noted on the dorsa of the hands was also significantly related to total exposure to PUVA (p less than .05, F-test). Our findings indicate that long-term PUVA exposure is associated with an increase in clinical actinic degeneration of the skin. However, the magnitude of this increase is small and, after more than 5 years, is of limited clinical consequence to most patients.
为了确定与口服甲氧沙林光化学疗法(PUVA)相关的临床光化性损伤程度,16所大学中心的皮肤科医生对1380例接受PUVA治疗的患者的臀部和手背的皱纹、毛细血管扩张及皮肤纹理改变情况进行了评估。这些变化与长期暴露于阳光下的皮肤所见相似。经过5年多的前瞻性研究,接受PUVA治疗的银屑病患者臀部皮肤临床光化性退变的患病率呈显著剂量依赖性增加(p小于0.05,F检验)。高剂量PUVA(超过160次治疗)患者中中度或重度改变的患病率较低(11%)。手背部临床光化性退变增加的程度也与PUVA总暴露量显著相关(p小于0.05,F检验)。我们的研究结果表明,长期暴露于PUVA与皮肤临床光化性退变增加有关。然而,这种增加幅度较小,且5年多后,对大多数患者的临床影响有限。